Allena Pharmaceuticals Reports Positive Reloxaliase Topline Results from URIROX-1 Trial and from Study 206

NEXT STORY
Lexicon Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides a Business Update
PREV STORY
Jounce Therapeutics Reports Third Quarter 2019 Financial Results
Subscribe to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Atlantic Healthcare Hosts Key Opinion Leader Discussion on Unmet Medical Need in Ulcerative Colitis and the Advantages of Alicaforsen

author_avatar
NASDAQ Market News

10x Genomics Reports Third Quarter 2019 Financial Results and Provides 2019 Revenue Guidance

author_avatar
NASDAQ Market News

Half-Year Report

author_avatar
NASDAQ Market News